Depression is a common comorbidity among HIV-infected individuals. We studied the relationship between depressive symptoms, risk behaviors (risky-sexual behavior, tobacco, alcohol, and illicit drug use) and HIV outcomes. This crosssectional study conducted in 2009 at the Washington University HIV Clinic included screening for depression with patient health questionnaire, survey of sexual behavior, illicit drug, alcohol, and tobacco use within 30 days. Sociodemographics, plasma HIV RNA levels, CD4 cell counts, and sexually transmitted disease test results were obtained from medical records. Multivariate logistic and linear regression models were used to assess the association between depressive symptoms severity and risk behaviors, HIV outcomes and combination antiretroviral therapy (cART) adherence. A total of 624 persons completed the assessment of whom 432 (69%) were male and 426 (68%) AfricanAmerican. The median CD4 cell count was 410 cells/mm 3 and 479 persons (77%) were on cART of whom 112 (23%) had HIV RNA level > 400 copies/mL. Overall, 96 (15%) had symptoms of major depressive disorder. Depressive symptom severity was associated with increased likelihood of high-risk drinking (odds ratio [OR], 2.4; 95% confidence interval [CI], 1.1-5.1), current tobacco use (OR, 1.8; 95% CI, 1.1-2.9), illicit drug use (OR, 1.7; 95% CI, 1.0-2.8), and risky-sexual behavior (OR, 1.5; 95% CI, 0.8-2.7). Suboptimal cART adherence (visual analog scale < 95%) was also associated with depressive symptoms severity (p < 0.05). After adjustment for age, sex, race, receipt of cART, and cART adherence, depressive symptoms severity was independently associated with lower CD4 cell count (p < 0.05) but not with higher HIV RNA level (p = 0.39). Depression adversely affects HIV-infected individuals, requiring greater effort at utilizing multidisciplinary interventions.
Introduction
Depression is a major comorbidity among the HIVinfected population (Benton, 2008) with prevalence reaching as high as 48% depending on study (Rabkin, 2008) . A national study of the prevalence of psychopathology in an HIV-infected population assessed 2864 individuals and estimated the prevalence of major depression to be 22% (Orlando et al., 2002) .
Depressive symptoms have been associated with poor HIV-related outcomes, such as rapid progression of HIV disease, higher mortality rates, poor adherence to cART, and higher HIV viral loads Horberg et al., 2008; Ickovics et al., 2001; Shacham, Nurutdinova, Satyanarayana, Stamm, & Overton, 2009; Vinet-Oliphant et al., 2010) . Depression has also been associated with high-risk behaviors: alcohol use in both HIV-infected and HIV-negative individuals (Sullivan, Goulet, Justice, & Fiellin, 2011) and illicit drug use (Berger-Greenstein et al., 2007; Bing et al., 2001) . Data on tobacco use and depression in HIV-infected individuals are limited (Reisen et al., 2011) . Depressive symptoms have been associated with diminished libido (Williams & Reynolds, 2006) , but the few available studies examining the relationship between risky-sexual behaviors and depression in HIV-infected individuals have provided inconsistent results (Bradley, Remien, & Dolezal, 2008; Shacham, Basta, & Reece, 2009; Williams & Latkin, 2005) . The majority of these studies assessed associations between high-risk behaviors and major depression, but none assessed whether the severity of depressive symptoms correlates with an increased probability of engaging in high-risk behaviors among individuals with HIV infection.
The primary objectives of this study were to characterize major depressive symptoms in a cohort of people living with HIV/AIDS who are engaged in care and to assess the relationship between depressive symptoms severity and the probability of engaging in high-risk behaviors. We hypothesized that increased severity of depressive symptoms was associated with increased probability of engaging in high-risk behaviors. The secondary objective was to assess the relationship between severity of depressive symptoms and HIV-related outcomes. Our hypothesis was that symptoms of depression were associated with lower CD4 cell counts and a higher HIV RNA level.
Measures and methods

Study population
This cross-sectional study using behavioral assessments was conducted as part of standard patient care among individuals aged ≥18 years presenting for care at the Washington University HIV outpatient clinic between June and September 2009. Data including CD4 cell count (current and nadir), plasma HIV RNA level and receipt of cART were collected from medical records. Sexually transmitted diseases (STD) test results (urinary nucleic acid amplification testing for Chlamydia trachomatis and Neisseria gonorrhea and rapid plasma reagin for syphilis) within the previous 12 months from the most recent visit were collected. The study was approved by the Washington University Human Research Protection Office.
Behavioral assessment
Behavioral assessments are conducted annually as part of standard patient care. Since most patients visit clinic every three months, we conducted our assessment in a threemonth period in an attempt to cover all the patients. Trained medical assistants performed interviews with each patient in the examining room prior to the physician encounter, and the collected information was stored directly to the medical records. Data regarding sociodemographics, depressive symptoms, and behavioral risk factors (unprotected sex and use of alcohol, illicit drugs and tobacco) were collected from these behavioral assessments.
Assessment of depression
Depressive symptoms were assessed by the patient health questionnaire (PHQ-9), which focuses on nine diagnostic criteria for Diagnostic and Statistical Manual of Mental Disorders, 4 th edition (DSM-IV) depressive disorders. The PHQ-9 has been validated for the diagnosis of major depressive disorder (MDD), other depressive disorder (ODD), and any depressive disorder (MDD or ODD) in diverse populations, including individuals living with HIV infection (Monahan et al., 2009) . We defined MDD as the presence of ≥5 of nine depressive symptoms at least "more than half the days" in the past 2 weeks, and one symptom of depressed mood or anhedonia (Kroenke, Spitzer, & Williams, 2001) . The PHQ-9 scores were categorized as no depression (0), minimal depression (1-4), mild depression (5-9), moderate depression (10-14), moderately severe depression (15) (16) (17) (18) (19) , and severe depression (20-27) (Kroenke et al., 2001 ).
Assessment of high-risk behaviors
Risky sexual behavior was defined as unprotected sex (no condom use at last sexual encounter and reporting never using condoms in the last 3 months) or positive STD test within 12 months. Illicit drug use was defined as use of marijuana, cocaine, methamphetamines, heroin, any opioid, inhalants, or any other illicit drugs within 30 days. High-risk drinking was defined as ≥14 drinks per week for men and ≥7 drinks for women as per the National Institute on Alcohol Abuse and Alcoholism (NIAAA) definition of "at-risk" or "heavy" drinking (Dawson, 2011) . Tobacco use within 30 days defined current use.
Adherence to cART was assessed using the visual analog scale (VAS), which requires participants to recall their adherence for the previous 30 days and estimate the percentage of medication doses (0-100%) that they had taken as prescribed (Giordano, Guzman, Clark, Charlebois, & Bangsberg, 2004; Kalichman et al., 2009 ). The VAS results were dichotomized to optimal adherence (≥95%) and suboptimal adherence (<95%) (Paterson et al., 2000; Reynolds et al., 2007) .
Statistical analysis
Descriptive analysis and bivariate analysis were conducted to assess the difference in characteristics between those with and without MDD symptoms. Chi-square analyses were used for dichotomous variables, and Mann-Whitney U test was used for nonparametric continuous variables. To assess the relationship between depressive symptoms severity and the probability of engaging in each risk behavior, multivariate logistic regression models were conducted. To assess the relationship between HIV-related outcomes (CD4 cell count and HIV RNA level) and severity of depressive symptoms, hierarchical linear regression models were used. All statistical analyses were performed using R 2.14.1 (R Foundation for Statistical Computing, Vienna, Austria), and posterior simulation of beta from linear regression models was performed using the sim function in the package arm (Gelman & Hill, 2006, pp. 44-45) to demonstrate the uncertainty of the fitted regression in the figure. Statistical significance was defined as p < 0.05.
Results
Association between MDD symptoms and high-risk behaviors
Of 624 individuals included, 432 (69%) were male, 426 (68%) African-American, and 96 (15%) reported MDD symptoms. Table 1 details further characteristics. There were 479 (77%) individuals on cART of which 49% was AIDS Care 1005 on protease inhibitor (PI)-based and 43% on nonnucleoside reverse transcriptase (NNRTI)-based regimen. Individuals with MDD symptoms were more often AfricanAmerican (81 vs. 66%, p < 0.05), less likely to be receiving cART (66 vs. 79%, p < 0.01), more likely to report illicit drug use (35 vs. 26%, p < 0.05), and be current smokers (66 vs. 44%, p < 0.001). Among those receiving cART, suboptimal adherence (VAS < 95%) was higher among individuals with MDD symptoms (38 vs. 24%, p < 0.01). Consequently, there was more virologic failure among individuals on cART with MDD symptoms than those with mild or no depressive symptoms (30 vs. 22%, p < 0.05). There were no significant differences in the proportion of individuals with MDD symptoms among those on either PI-based or NNRTI-based regimen. While risky-sexual behavior was common, neither risky-sexual behavior nor high-risk drinking was associated with MDD symptoms (p = 0.32 and 0.27, respectively). Among those with MDD symptoms, there were a higher proportion of individuals with low CD4 cell count of <200 cells/mm 3 (29 vs. 19%, p < 0.05) and HIV RNA level of >400 copies/mL (55 vs. 40%, p < 0.05), although these include those off cART. The length of time from HIV diagnosis was not associated with MDD symptoms (p = 0.89).
Association between depression severity and high-risk behaviors Figure 1 demonstrates the fitted logistic regression models estimating the probability of engagement to each risk behaviors by PHQ-9 score. These models were adjusted by age, gender, race, CD4 cell count, HIV RNA level, receipt of cART, and cART adherence. As the severity of depressive symptoms increased (higher PHQ-9 score), the probability of engaging in each risk behaviors increased. Although risky sexual behavior did not reach statistical significance (p = 0.33), there was a tendency (positive slope) for increased probability as severity of depression increased. Figure 2 illustrates the adjusted odds ratio (aOR) of individuals with PHQ-9 score ≥ 10 (moderate-to-severe depression) engaging in each risk behaviors. There was 2.4-fold (95% confidence interval [CI], 1.1-5.1) increased risk of high-risk drinking, 1.8-fold (95% CI, 1.1-2.9) increased risk of current tobacco use, 1.7-fold (95% CI, 1.0-2.8) increased risk of illicit drug use, and 1.5-fold (95% CI, 0.8-2.7) increased risk of engaging in risky sexual behavior in those with PHQ-9 scores ≥10 (all p < 0.05).
Association between cART adherence, depression, and high-risk behaviors In the univariate analyses, PI-based cART (odds ratio [OR], 1.9; 95% CI, 1.2-3.0), age ≤ 40 years (OR, 1.8; 95% CI, 1.2-2.8), presence of MDD (OR, 2.1; 95% CI, 1.2-3.6), African-American race (OR, 3.3; 95% CI, 1.9-5.7), high-risk drinking (OR, 2.2; 95% CI, 1.1-4.2), current tobacco use (OR, 1.9; 95% CI, 1.3-2.8), and illicit drug use (OR, 1.7; 95% CI, 1.1-2.6) were associated with increased risk of suboptimal adherence to cART (Supplemental material, Figure S1 ). Multivariate Figure 1 . Probability of each risk behaviors estimated by PHQ-9 scores. Fitted logistic regression estimating the probability of engaging in each risk behaviors by PHQ-9 scores. Jittered dots represent the PHQ-9 score data. These multivariate models are adjusted by age, sex, race, current CD4 count, Log HIV viral load, receipt of cART and cART adherence.
Figure 2. Adjusted odds ratios for depression (PHQ-9 ≥ 10) predicting each risk behavior. Adjusted by age, sex, race, HIV RNA level, current CD4 cell count, receipt of cART and cART adherence. 95% CI, reference for the odds ratios is no depression (PHQ-9 score of 0).
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logistic regression models were built to estimate suboptimal adherence to cART by the PHQ-9 score (Figure 3 ). VAS (cART adherence) was significantly associated with depression severity (p < 0.05) when adjusted by age, sex, and high-risk behaviors. Age ≤40 years (aOR, 1.7; 95% CI, 1.1-2.7), African-American race (aOR, 2.6; 95% CI, 1.4-4.9), use of PI-based cART (aOR, 1.6; 95% CI, 1.0-2.6), and current tobacco use (aOR, 1.8; 95% CI, 1.1-2.8) were also significantly associated with depression severity.
Effect of severity depressive symptoms on HIV-related outcomes
Hierarchical linear regression models predicting CD4 cell count (both current and nadir) and HIV RNA level from the PHQ-9 score were built, adjusted by age, gender, race, receipt of cART, and VAS. Table 2 summarizes both unstandardized and standardized coefficients of the two models; step 1 as an unadjusted and step 2 as an adjusted model. In the unadjusted models, both HIV RNA level and current CD4 cell count were associated with severity of depressive symptoms; a higher PHQ-9 score was associated with higher HIV RNA level and lower CD4 cell count (standardized beta = 0.18, 0.16, respectively, both p < 0.001). We did not detect an association between the nadir CD4 cell count and severity of depressive symptoms (p = 0.08) (Supplemental material, Table S1 and Figure S2 ). In the adjusted models, we failed to identify an independent association between HIV RNA level and PHQ-9 score, but current CD4 cell count was independently associated with the PHQ-9 score (standardized beta = 0.11, p < 0.05). Significant factors associated with lower HIV RNA level were receipt of cART (standardized beta = 0.42) and adherence to cART (standardized beta = 0.18). African-American race (standardized beta = 0.13) was associated with higher HIV RNA level. Significant factors predicting CD4 cell count were male sex (standardized beta = 0.14), African-American race (standardized beta = 0.13), receipt of cART (standardized beta = 0.15), and adherence to cART (standardized beta = 0.12). Figure 4 shows the plot and regression line of these models. HIV RNA level was associated with PHQ-9 score with a positive slope in the unadjusted model in the left indicating that HIV RNA level increased with higher PHQ-9 score, but in the adjusted model on the right the slope decreased, indicating no independent association. The current CD4 cell count was associated with PHQ-9 score in both unadjusted (left) and adjusted (right) models with negative slopes, indicating the decline of CD4 cell count was independently associated with an increase in PHQ-9 score. For final model, F 6,427 = 7.53, p < 0.001, R 2 = 0.083.
Discussion
Our data demonstrate that more than 15% of our clinic population had symptoms consistent with major depression, which is comparable to other studies (Bing et al., 2001; Ciesla & Roberts, 2001; Morrison et al., 2002) . This clinic-based study demonstrated that increases in severity of depressive symptoms were independently associated with a linear decline in current CD4 cell count, confirming that patients with advanced HIV disease are at greater risk of being affected by depressive symptoms. Compared to previous studies (Ickovics et al., 2001) , our study included not only receipt of cART but also adherence to cART. We have showed that individuals with severe depressive symptoms had suboptimal cART adherence. Another significant finding was that the increase in severity of depressive symptoms was associated with higher probability of engaging in highrisk drinking, tobacco, illicit drug use, and risky sexual behavior. Although association between severe depressive symptoms and risky sexual behaviors did not reach statistical significance, it did show a clear tendency. This may be due to the small number of individual included to this study, therefore underpowered. The study also illustrates that depression screening as standard of care identifies at-risk patients and increases intervention opportunities for clinic providers, such as counseling and pharmacotherapy. Additionally, those with depression should be screened for engagement in high-risk behaviors, particularly given the independent association between these parameters. There was a concern that patients under care for longer periods had a higher probability of having treated for comorbid conditions, such as depression and other high-risk behaviors, and analyzing these patients with others who engaged in HIV care recently may bias the results. We hypothesized that the years from diagnosis served to control for better HIV AIDS Care 1009 management, but univariate analyses did not show any differences in the proportion of individuals with MDD symptoms and adjustment of multivariate model did not differ from the results shown. Therefore, length of time with HIV did not contribute to our model, highlighting the importance of periodic screening of depression and high-risk behaviors during routine patient care. We have previously described the association between virologic suppression and depressive disorders in individuals with HIV infection receiving cART and showed a 2.5-fold increased risk of detectable viral load (HIV RNA level of >400 copies/mL) in depressed patients ). In this current study, the association between depressive symptoms and uncontrolled virema was confirmed although it was mediated through inadequate adherence to cART. We then hypothesized that high levels of viremia may be contributing to worse depressive symptoms, but failed to identify independent linear association between PHQ-9 score and HIV RNA level. This finding is important since increase in HIV viral load (high level of viremia) itself did not have association with increase in depression severity, as shown in previous studies . These data suggest that depression may not be caused by the HIV infection itself, and that effective control of depressive symptoms can have potential benefit for management of HIV disease.
We also evaluated risk factors for suboptimal adherence to cART. Given that the current adult treatment guidelines (Thompson, 2012) recommend cART for all HIV-infected individuals, delineating the risk factors for nonadherence will provide insight for the development of effective interventions. As predicted, we demonstrated that depressive symptoms indeed impact cART adherence. This relationship is particularly relevant given the evolution of HIV infection into a chronic disease state for which long-term adherence will prove critical to success.
There are limitations to this study. This was a single site study, and some of the statistical analyses were underpowered by the number of individuals included as previously mentioned. This was a cross-sectional study; therefore, we are unsure of the directionality of the relationships identified. While we covered a large proportion of our clinic patients, there were patients who did not show to the clinic appointment and potentially missed three-month period that we conducted the behavioral assessment. This may cause bias since the reason for not showing up to the clinic may be due to psychiatric illnesses, behavioral problems, or other comorbidities. The measurement of adherence to cART using the VAS is limited in scope, as some studies have failed to demonstrate an association between the VAS and objective measures of adherence (Gill et al., 2010; Pearson, Simoni, Hoff, Kurth, & Martin, 2007) . The definition of each high-risk behavior may lack adequate sensitivity or specificity. For example, the definition of high-risk drinking may underestimate the individuals at risk for alcohol dependence in the HIV-infected population (Shacham, Agbebi, Stamm, & Overton, 2011) . The length of time with HIV does not necessarily represent the length of care. We are assuming that majority of the HIV diagnosed individuals enter to care right away, which is likely to be an inappropriate assumption. The behavioral assessment was conducted face-to-face, which may cause reporting bias, as people tend to underreport their engagement in risk behaviors when assessment is performed in such manner (Newman et al., 2002; Schackman et al., 2008) . The next step will be to implement a computer-assisted self-interview (CASI), which reduces reporting bias and allows prompt provider feedback of the behavioral assessment and to obtain longitudinal data to study the causal directions (Johnson et al., 2001 ).
In conclusion, the results highlight associations between severity of depressive symptoms and engagement in high-risk behaviors and markers of advanced HIV disease. Our results support the implementation of routine screening for depression and high-risk behaviors in HIV clinics and multidisciplinary interventions to improve outcomes among depressed HIV-infected individuals.
